doi	title	authors	title_name	year	downloads	visitors	countries
10.1200/jco.2012.45.2011	Liquid Biopsies: Genotyping Circulating Tumor DNA	Luis A. Diaz, Alberto Bardelli	Journal of Clinical Oncology	2014	126	110	26
10.1200/jco.2014.60.1799	Update on Metastatic Gastric and Esophageal Cancers	Manish A. Shah	Journal of Clinical Oncology	2015	51	44	16
10.1200/jco.2014.59.3665	Next-Generation Sequencing Panels for the Diagnosis of Colorectal Cancer and Polyposis Syndromes: A Cost-Effectiveness Analysis	Carlos J. Gallego, Brian H. Shirts, Caroline S. Bennette, Greg Guzauskas, Laura M. Amendola, Martha Horike-Pyne, Fuki M. Hisama, Colin C. Pritchard, William M. Grady, Wylie Burke, Gail P. Jarvik, David L. Veenstra	Journal of Clinical Oncology	2015	48	42	18
10.1200/jco.2014.59.7633	Metastatic Colorectal Cancer: Current State and Future Directions	Marwan G. Fakih	Journal of Clinical Oncology	2015	47	42	15
10.1200/jco.2013.54.8800	Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification	Bruce D. Cheson, Richard I. Fisher, Sally F. Barrington, Franco Cavalli, Lawrence H. Schwartz, Emanuele Zucca, T. Andrew Lister	Journal of Clinical Oncology	2014	33	33	21
10.1200/jco.2014.60.0213	Personalizing Colon Cancer Adjuvant Therapy: Selecting Optimal Treatments for Individual Patients	Rodrigo Dienstmann, Ramon Salazar, Josep Tabernero	Journal of Clinical Oncology	2015	34	33	18
10.1200/jco.2014.58.0225	Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma	N. Ahmed, V. S. Brawley, M. Hegde, C. Robertson, A. Ghazi, C. Gerken, E. Liu, O. Dakhova, A. Ashoori, A. Corder, T. Gray, M.-F. Wu, H. Liu, J. Hicks, N. Rainusso, G. Dotti, Z. Mei, B. Grilley, A. Gee, C. M. Rooney, M. K. Brenner, H. E. Heslop, W. S. Wels, L. L. Wang, P. Anderson, S. Gottschalk	Journal of Clinical Oncology	2015	43	30	5
10.1200/jco.2014.60.6764	Screening in GI Cancers: The Role of Genetics	Elena M. Stoffel	Journal of Clinical Oncology	2015	39	30	11
10.1200/jco.2014.58.2007	Molecular Profiling and Targeted Therapy for Advanced Thoracic Malignancies: A Biomarker-Derived, Multiarm, Multihistology Phase II Basket Trial	Ariel Lopez-Chavez, Anish Thomas, Arun Rajan, Mark Raffeld, Betsy Morrow, Ronan Kelly, Corey Allan Carter, Udayan Guha, Keith Killian, Christopher C. Lau, Zied Abdullaev, Liqiang Xi, Svetlana Pack, Paul S. Meltzer, Christopher L. Corless, Alan Sandler, Carol Beadling, Andrea Warrick, David J. Liewehr, Seth M. Steinberg, Arlene Berman, Austin Doyle, Eva Szabo, Yisong Wang, Giuseppe Giaccone	Journal of Clinical Oncology	2015	33	28	8
10.1200/jco.2014.59.7799	Role of Physical Activity and Diet After Colorectal Cancer Diagnosis	Erin L. Van Blarigan, Jeffrey A. Meyerhardt	Journal of Clinical Oncology	2015	33	27	11
10.1200/jco.2014.59.5298	Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance)	Hope S. Rugo, William T. Barry, Alvaro Moreno-Aspitia, Alan P. Lyss, Constance Cirrincione, Eleanor Leung, Erica L. Mayer, Michael Naughton, Deborah Toppmeyer, Lisa A. Carey, Edith A. Perez, Clifford Hudis, Eric P. Winer	Journal of Clinical Oncology	2015	26	26	10
10.1200/jco.2014.59.7765	Controversies in the Treatment of Local and Locally Advanced Gastric and Esophageal Cancers	Deirdre J. Cohen, Lawrence Leichman	Journal of Clinical Oncology	2015	33	26	12
10.1200/jco.2014.56.2025	Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor	James N. Kochenderfer, Mark E. Dudley, Sadik H. Kassim, Robert P.T. Somerville, Robert O. Carpenter, Maryalice Stetler-Stevenson, James C. Yang, Giao Q. Phan, Marybeth S. Hughes, Richard M. Sherry, Mark Raffeld, Steven Feldman, Lily Lu, Yong F. Li, Lien T. Ngo, Andre Goy, Tatyana Feldman, David E. Spaner, Michael L. Wang, Clara C. Chen, Sarah M. Kranick, Avindra Nath, Debbie-Ann N. Nathan, Kathleen E. Morton, Mary Ann Toomey, Steven A. Rosenberg	Journal of Clinical Oncology	2015	25	25	9
10.1200/jco.2014.58.3708	Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer	Scott N. Gettinger, Leora Horn, Leena Gandhi, David R. Spigel, Scott J. Antonia, Naiyer A. Rizvi, John D. Powderly, Rebecca S. Heist, Richard D. Carvajal, David M. Jackman, Lecia V. Sequist, David C. Smith, Philip Leming, David P. Carbone, Mary C. Pinder-Schenck, Suzanne L. Topalian, F. Stephen Hodi, Jeffrey A. Sosman, Mario Sznol, David F. McDermott, Drew M. Pardoll, Vindira Sankar, Christoph M. Ahlers, Mark Salvati, Jon M. Wigginton, Matthew D. Hellmann, Georgia D. Kollia, Ashok K. Gupta, Julie R. Brahmer	Journal of Clinical Oncology	2015	35	25	10
10.1200/jco.2014.59.4424	BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non–Small-Cell Lung Cancer	Caicun Zhou, Yi-Long Wu, Gongyan Chen, Xiaoqing Liu, Yunzhong Zhu, Shun Lu, Jifeng Feng, Jianxing He, Baohui Han, Jie Wang, Guoliang Jiang, Chunhong Hu, Hao Zhang, Gang Cheng, Xiangqun Song, You Lu, Hongming Pan, Wenjuan Zheng, Anny-Yue Yin	Journal of Clinical Oncology	2015	28	23	4
10.1200/jco.2014.55.3487	Circulating Tumor Cell Biomarker Panel As an Individual-Level Surrogate for Survival in Metastatic Castration-Resistant Prostate Cancer	Howard I. Scher, Glenn Heller, Arturo Molina, Gerhardt Attard, Daniel C. Danila, Xiaoyu Jia, Weimin Peng, Shahneen K. Sandhu, David Olmos, Ruth Riisnaes, Robert McCormack, Tomasz Burzykowski, Thian Kheoh, Martin Fleisher, Marc Buyse, Johann S. de Bono	Journal of Clinical Oncology	2015	23	22	9
10.1200/jco.2014.55.4139	Past, Present, and Future Challenges in Breast Cancer Treatment	George W. Sledge, Eleftherios P. Mamounas, Gabriel N. Hortobagyi, Harold J. Burstein, Pamela J. Goodwin, Antonio C. Wolff	Journal of Clinical Oncology	2014	24	22	14
10.1200/jco.2014.58.1736	Impact of Specific Epidermal Growth Factor Receptor (EGFR) Mutations and Clinical Characteristics on Outcomes After Treatment With EGFR Tyrosine Kinase Inhibitors Versus Chemotherapy in EGFR-Mutant Lung Cancer: A Meta-Analysis	Chee Khoon Lee, Yi-Long Wu, Pei Ni Ding, Sarah J. Lord, Akira Inoue, Caicun Zhou, Tetsuya Mitsudomi, Rafael Rosell, Nick Pavlakis, Matthew Links, Val Gebski, Richard J. Gralla, James Chih-Hsin Yang	Journal of Clinical Oncology	2015	22	20	8
10.1200/jco.2014.59.1081	Effect of Low-Intensity Physical Activity and Moderate- to High-Intensity Physical Exercise During Adjuvant Chemotherapy on Physical Fitness, Fatigue, and Chemotherapy Completion Rates: Results of the PACES Randomized Clinical Trial	Hanna van Waart, Martijn M. Stuiver, Wim H. van Harten, Edwin Geleijn, Jacobien M. Kieffer, Laurien M. Buffart, Marianne de Maaker-Berkhof, Epie Boven, Jolanda Schrama, Maud M. Geenen, Jetske M. Meerum Terwogt, Aart van Bochove, Vera Lustig, Simone M. van den Heiligenberg, Carolien H. Smorenburg, Jeannette A.J.H. Hellendoorn-van Vreeswijk, Gabe S. Sonke, Neil K. Aaronson	Journal of Clinical Oncology	2015	22	20	11
10.1200/jco.2014.59.7344	GI Stromal Tumors: 15 Years of Lessons From a Rare Cancer	Angela Cioffi, Robert G. Maki	Journal of Clinical Oncology	2015	20	20	15
10.1200/jco.2014.60.1591	Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog–Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032	Giles W. Robinson, Brent A. Orr, Gang Wu, Sridharan Gururangan, Tong Lin, Ibrahim Qaddoumi, Roger J. Packer, Stewart Goldman, Michael D. Prados, Annick Desjardins, Murali Chintagumpala, Naoko Takebe, Sue C. Kaste, Michael Rusch, Sariah J. Allen, Arzu Onar-Thomas, Clinton F. Stewart, Maryam Fouladi, James M. Boyett, Richard J. Gilbertson, Tom Curran, David W. Ellison, Amar Gajjar	Journal of Clinical Oncology	2015	24	20	7
10.1200/jco.2014.60.2532	Carcinoid and Neuroendocrine Tumors: Building on Success	Pamela L. Kunz	Journal of Clinical Oncology	2015	22	20	10
10.1200/jco.2014.56.2736	Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma	Dirk Schadendorf, F. Stephen Hodi, Caroline Robert, Jeffrey S. Weber, Kim Margolin, Omid Hamid, Debra Patt, Tai-Tsang Chen, David M. Berman, Jedd D. Wolchok	Journal of Clinical Oncology	2015	21	19	13
10.1200/jco.2014.58.3302	Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort	Julien Mazières, Gérard Zalcman, Lucio Crinò, Pamela Biondani, Fabrice Barlesi, Thomas Filleron, Anne-Marie C. Dingemans, Hervé Léna, Isabelle Monnet, Sacha I. Rothschild, Federico Cappuzzo, Benjamin Besse, Luc Thiberville, Damien Rouvière, Rafal Dziadziuszko, Egbert F. Smit, Jurgen Wolf, Christian Spirig, Nicolas Pecuchet, Frauke Leenders, Johannes M. Heuckmann, Joachim Diebold, Julie D. Milia, Roman K. Thomas, Oliver Gautschi	Journal of Clinical Oncology	2015	25	19	9
10.1200/jco.2014.59.7625	Progress in the Treatment of Metastatic Pancreatic Cancer and the Search for Next Opportunities	Andrew H. Ko	Journal of Clinical Oncology	2015	19	19	12
10.1200/jco.2014.60.0379	Toxicities of Immunotherapy for the Practitioner	Jeffrey S. Weber, James C. Yang, Michael B. Atkins, Mary L. Disis	Journal of Clinical Oncology	2015	19	19	14
10.1200/jco.2014.60.3449	Chimeric Antigen Receptor T Cells for Cancer Immunotherapy	K. J. Curran, R. J. Brentjens	Journal of Clinical Oncology	2015	22	19	4
10.1200/jco.2014.58.8848	Poly (ADP-Ribose) Polymerase Inhibitors: Recent Advances and Future Development	Clare L. Scott, Elizabeth M. Swisher, Scott H. Kaufmann	Journal of Clinical Oncology	2015	19	18	9
10.1200/jco.2013.51.4489	Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial	Eric Pujade-Lauraine, Felix Hilpert, Béatrice Weber, Alexander Reuss, Andres Poveda, Gunnar Kristensen, Roberto Sorio, Ignace Vergote, Petronella Witteveen, Aristotelis Bamias, Deolinda Pereira, Pauline Wimberger, Ana Oaknin, Mansoor Raza Mirza, Philippe Follana, David Bollag, Isabelle Ray-Coquard	Journal of Clinical Oncology	2014	18	17	7
10.1200/jco.2013.54.1870	Luminal B Breast Cancer: Molecular Characterization, Clinical Management, and Future Perspectives	Felipe Ades, Dimitrios Zardavas, Ivana Bozovic-Spasojevic, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Giuseppe Viale, Christos Sotiriou, Martine Piccart	Journal of Clinical Oncology	2014	19	17	10
10.1200/jco.2014.56.5689	Genetic Diagnosis of High-Penetrance Susceptibility for Colorectal Cancer (CRC) Is Achievable for a High Proportion of Familial CRC by Exome Sequencing	Daniel Chubb, Peter Broderick, Matthew Frampton, Ben Kinnersley, Amy Sherborne, Steven Penegar, Amy Lloyd, Yussanne P. Ma, Sara E. Dobbins, Richard S. Houlston	Journal of Clinical Oncology	2015	17	17	7
10.1200/jco.2014.57.0085	Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation–Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105	Melinda L. Telli, Kristin C. Jensen, Shaveta Vinayak, Allison W. Kurian, Jafi A. Lipson, Patrick J. Flaherty, Kirsten Timms, Victor Abkevich, Elizabeth A. Schackmann, Irene L. Wapnir, Robert W. Carlson, Pei-Jen Chang, Joseph A. Sparano, Bobbie Head, Lori J. Goldstein, Barbara Haley, Shaker R. Dakhil, Julia E. Reid, Anne-Renee Hartman, Judith Manola, James M. Ford	Journal of Clinical Oncology	2015	24	17	5
10.1200/jco.2014.59.7591	Biliary Tract Cancers: Understudied and Poorly Understood	Emily Chan, Jordan Berlin	Journal of Clinical Oncology	2015	18	17	11
10.1200/jco.2014.60.1054	Advances and Challenges in Treatment of Locally Advanced Rectal Cancer	J. Joshua Smith, Julio Garcia-Aguilar	Journal of Clinical Oncology	2015	19	17	11
10.1200/jco.2014.58.1041	Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab	David F. McDermott, Charles G. Drake, Mario Sznol, Toni K. Choueiri, John D. Powderly, David C. Smith, Julie R. Brahmer, Richard D. Carvajal, Hans J. Hammers, Igor Puzanov, F. Stephen Hodi, Harriet M. Kluger, Suzanne L. Topalian, Drew M. Pardoll, Jon M. Wigginton, Georgia D. Kollia, Ashok Gupta, Dan McDonald, Vindira Sankar, Jeffrey A. Sosman, Michael B. Atkins	Journal of Clinical Oncology	2015	19	16	9
10.1200/jco.2014.59.4358	Immune Checkpoint Blockade in Cancer Therapy	Michael A. Postow, Margaret K. Callahan, Jedd D. Wolchok	Journal of Clinical Oncology	2015	17	16	13
10.1200/jco.2014.59.9324	Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin According to Thymidylate Synthase Expression in Nonsquamous Non–Small-Cell Lung Cancer: A Biomarker-Stratified Randomized Phase II Trial	Jong-Mu Sun, Jin Seok Ahn, Sin-Ho Jung, Jiyu Sun, Sang Yun Ha, Joungho Han, Keunchil Park, Myung-Ju Ahn	Journal of Clinical Oncology	2015	16	16	3
10.1200/jco.2015.60.7879	Immune Therapy in GI Malignancies: A Review	Judy Wang, Kim A. Reiss, Rina Khatri, Elizabeth Jaffee, Dan Laheru	Journal of Clinical Oncology	2015	16	16	11
10.1200/jco.2015.61.1459	Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline	Catherine Van Poznak, Mark R. Somerfield, Robert C. Bast, Massimo Cristofanilli, Matthew P. Goetz, Ana M. Gonzalez-Angulo, David G. Hicks, Elizabeth G. Hill, Minetta C. Liu, Wanda Lucas, Ingrid A. Mayer, Robert G. Mennel, William F. Symmans, Daniel F. Hayes, Lyndsay N. Harris	Journal of Clinical Oncology	2015	17	16	10
10.1200/jco.2013.51.7219	Pain and Nociception: Mechanisms of Cancer-Induced Bone Pain	Sarah Falk, Anthony H. Dickenson	Journal of Clinical Oncology	2014	19	15	11
10.1200/jco.2014.57.1794	CEREBEL (EGF111438): A Phase III, Randomized, Open-Label Study of Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer	Xavier Pivot, Alexey Manikhas, Bogdan Żurawski, Ewa Chmielowska, Boguslawa Karaszewska, Rozenn Allerton, Stephen Chan, Alessandra Fabi, Paolo Bidoli, Stefania Gori, Eva Ciruelos, Magdolna Dank, Lajos Hornyak, Sara Margolin, Arnd Nusch, Roma Parikh, Fareha Nagi, Michelle DeSilvio, Sergio Santillana, Ramona F. Swaby, Vladimir Semiglazov	Journal of Clinical Oncology	2015	24	15	7
10.1200/jco.2014.57.6660	TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer	Steven J. Isakoff, Erica L. Mayer, Lei He, Tiffany A. Traina, Lisa A. Carey, Karen J. Krag, Hope S. Rugo, Minetta C. Liu, Vered Stearns, Steven E. Come, Kirsten M. Timms, Anne-Renee Hartman, Darrel R. Borger, Dianne M. Finkelstein, Judy E. Garber, Paula D. Ryan, Eric P. Winer, Paul E. Goss, Leif W. Ellisen	Journal of Clinical Oncology	2015	19	15	5
10.1200/jco.2014.55.2158	PIK3CA Mutations Are Associated With Decreased Benefit to Neoadjuvant Human Epidermal Growth Factor Receptor 2–Targeted Therapies in Breast Cancer	Ian J. Majewski, Paolo Nuciforo, Lorenza Mittempergher, Astrid J. Bosma, Holger Eidtmann, Eileen Holmes, Christos Sotiriou, Debora Fumagalli, Jose Jimenez, Claudia Aura, Ludmila Prudkin, Maria Carmen Díaz-Delgado, Lorena de la Peña, Sherene Loi, Catherine Ellis, Nikolaus Schultz, Evandro de Azambuja, Nadia Harbeck, Martine Piccart-Gebhart, René Bernards, José Baselga	Journal of Clinical Oncology	2015	15	14	5
10.1200/jco.2014.55.8262	Entering the Era of Targeted Therapy for Chronic Lymphocytic Leukemia: Impact on the Practicing Clinician	John C. Byrd, Jeffrey J. Jones, Jennifer A. Woyach, Amy J. Johnson, Joseph M. Flynn	Journal of Clinical Oncology	2014	22	14	8
10.1200/jco.2014.56.6661	Development and Validation of a Nomogram for Predicting Survival in Patients With Resected Non–Small-Cell Lung Cancer	Wenhua Liang, Li Zhang, Gening Jiang, Qun Wang, Lunxu Liu, Deruo Liu, Zheng Wang, Zhihua Zhu, Qiuhua Deng, Xinguo Xiong, Wenlong Shao, Xiaoshun Shi, Jianxing He	Journal of Clinical Oncology	2015	15	14	2
10.1200/jco.2014.57.8963	Accurate Prediction and Validation of Response to Endocrine Therapy in Breast Cancer	Arran K. Turnbull, Laura M. Arthur, Lorna Renshaw, Alexey A. Larionov, Charlene Kay, Anita K. Dunbier, Jeremy S. Thomas, Mitch Dowsett, Andrew H. Sims, J. Michael Dixon	Journal of Clinical Oncology	2015	17	14	5
10.1200/jco.2014.57.9961	Role of Magnetic Resonance Imaging in the Management of Patients With Multiple Myeloma: A Consensus Statement	Meletios A. Dimopoulos, Jens Hillengass, Saad Usmani, Elena Zamagni, Suzanne Lentzsch, Faith E. Davies, Noopur Raje, Orhan Sezer, Sonja Zweegman, Jatin Shah, Ashraf Badros, Kazuyuki Shimizu, Philippe Moreau, Chor-Sang Chim, Juan José Lahuerta, Jian Hou, Artur Jurczyszyn, Hartmut Goldschmidt, Pieter Sonneveld, Antonio Palumbo, Heinz Ludwig, Michele Cavo, Bart Barlogie, Kenneth Anderson, G. David Roodman, S. Vincent Rajkumar, Brian G.M. Durie, Evangelos Terpos	Journal of Clinical Oncology	2015	14	14	10
10.1200/jco.2014.58.4904	First- and Second-Line Bevacizumab in Addition to Chemotherapy for Metastatic Colorectal Cancer: A United States–Based Cost-Effectiveness Analysis	Daniel A. Goldstein, Qiushi Chen, Turgay Ayer, David H. Howard, Joseph Lipscomb, Bassel F. El-Rayes, Christopher R. Flowers	Journal of Clinical Oncology	2015	15	14	2
10.1200/jco.2014.58.5380	Postoperative Radiotherapy for Pathologic N2 Non–Small-Cell Lung Cancer Treated With Adjuvant Chemotherapy: A Review of the National Cancer Data Base	Cliff G. Robinson, Aalok P. Patel, Jeffrey D. Bradley, Todd DeWees, Saiama N. Waqar, Daniel Morgensztern, Maria Q. Baggstrom, Ramaswamy Govindan, Jennifer M. Bell, Tracey J. Guthrie, Graham A. Colditz, Traves D. Crabtree, Daniel Kreisel, Alexander S. Krupnick, G. Alexander Patterson, Bryan F. Meyers, Varun Puri	Journal of Clinical Oncology	2015	14	14	9
10.1200/jco.2014.59.0489	Overall Response Rate, Progression-Free Survival, and Overall Survival With Targeted and Standard Therapies in Advanced Non–Small-Cell Lung Cancer: US Food and Drug Administration Trial-Level and Patient-Level Analyses	Gideon M. Blumenthal, Stella W. Karuri, Hui Zhang, Lijun Zhang, Sean Khozin, Dickran Kazandjian, Shenghui Tang, Rajeshwari Sridhara, Patricia Keegan, Richard Pazdur	Journal of Clinical Oncology	2015	14	14	8
10.1200/jco.2014.59.5728	Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers	Gaëlle Bougeard, Mariette Renaux-Petel, Jean-Michel Flaman, Camille Charbonnier, Pierre Fermey, Muriel Belotti, Marion Gauthier-Villars, Dominique Stoppa-Lyonnet, Emilie Consolino, Laurence Brugières, Olivier Caron, Patrick R. Benusiglio, Brigitte Bressac-de Paillerets, Valérie Bonadona, Catherine Bonaïti-Pellié, Julie Tinat, Stéphanie Baert-Desurmont, Thierry Frebourg	Journal of Clinical Oncology	2015	18	14	12
10.1200/jco.2014.59.7930	Approach to Patients With Pancreatic Cancer Without Detectable Metastases	Gregory M. Heestand, James D. Murphy, Andrew M. Lowy	Journal of Clinical Oncology	2015	14	14	9
10.1200/jco.2013.52.6863	Prevalence and Functional Consequence of TP53 Mutations in Pediatric Adrenocortical Carcinoma: A Children's Oncology Group Study	Jonathan D. Wasserman, Ana Novokmet, Claudia Eichler-Jonsson, Raul C. Ribeiro, Carlos Rodriguez-Galindo, Gerard P. Zambetti, David Malkin	Journal of Clinical Oncology	2015	13	13	10
10.1200/jco.2013.53.0105	Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab	Suzanne L. Topalian, Mario Sznol, David F. McDermott, Harriet M. Kluger, Richard D. Carvajal, William H. Sharfman, Julie R. Brahmer, Donald P. Lawrence, Michael B. Atkins, John D. Powderly, Philip D. Leming, Evan J. Lipson, Igor Puzanov, David C. Smith, Janis M. Taube, Jon M. Wigginton, Georgia D. Kollia, Ashok Gupta, Drew M. Pardoll, Jeffrey A. Sosman, F. Stephen Hodi	Journal of Clinical Oncology	2014	16	13	9
10.1200/jco.2013.54.1011	Prospective, Randomized, Multicenter, Phase III Study of Fluorouracil, Leucovorin, and Irinotecan Versus Epirubicin, Cisplatin, and Capecitabine in Advanced Gastric Adenocarcinoma: A French Intergroup (Fédération Francophone de Cancérologie Digestive, Fédération Nationale des Centres de Lutte Contre le Cancer, and Groupe Coopérateur Multidisciplinaire en Oncologie) Study	Rosine Guimbaud, Christophe Louvet, Pauline Ries, Marc Ychou, Emilie Maillard, Thierry André, Jean-Marc Gornet, Thomas Aparicio, Suzanne Nguyen, Ahmed Azzedine, Pierre-Luc Etienne, Eveline Boucher, Christine Rebischung, Pascal Hammel, Philippe Rougier, Laurent Bedenne, Olivier Bouché	Journal of Clinical Oncology	2014	14	13	9
10.1200/jco.2014.55.5763	Pharmacokinetic and Pharmacodynamic Properties of Calaspargase Pegol Escherichia coli L-Asparaginase in the Treatment of Patients With Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Study AALL07P4	Anne L. Angiolillo, Reuven J. Schore, Meenakshi Devidas, Michael J. Borowitz, Andrew J. Carroll, Julie M. Gastier-Foster, Nyla A. Heerema, Taha Keilani, Ashley R. Lane, Mignon L. Loh, Gregory H. Reaman, Peter C. Adamson, Brent Wood, Charlotte Wood, Hao W. Zheng, Elizabeth A. Raetz, Naomi J. Winick, William L. Carroll, Stephen P. Hunger	Journal of Clinical Oncology	2014	23	13	4
10.1200/jco.2014.56.2728	Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation	Bella Kaufman, Ronnie Shapira-Frommer, Rita K. Schmutzler, M. William Audeh, Michael Friedlander, Judith Balmaña, Gillian Mitchell, Georgeta Fried, Salomon M. Stemmer, Ayala Hubert, Ora Rosengarten, Mariana Steiner, Niklas Loman, Karin Bowen, Anitra Fielding, Susan M. Domchek	Journal of Clinical Oncology	2015	15	13	5
10.1200/jco.2014.58.3831	Active Smoking and Mortality Among Colorectal Cancer Survivors: The Cancer Prevention Study II Nutrition Cohort	Baiyu Yang, Eric J. Jacobs, Susan M. Gapstur, Victoria Stevens, Peter T. Campbell	Journal of Clinical Oncology	2015	13	13	7
10.1200/jco.2014.60.0759	Targeting Tumor Hypoxia With Hypoxia-Activated Prodrugs	Jen Jen Yeh, William Y. Kim	Journal of Clinical Oncology	2015	13	13	9
10.1200/jco.2013.50.8267	Randomized, Controlled, Double-Blind, Cross-Over Trial Assessing Treatment Preference for Pazopanib Versus Sunitinib in Patients With Metastatic Renal Cell Carcinoma: PISCES Study	Bernard Escudier, Camillo Porta, Petri Bono, Thomas Powles, Tim Eisen, Cora N. Sternberg, Jürgen E. Gschwend, Ugo De Giorgi, Omi Parikh, Robert Hawkins, Emmanuel Sevin, Sylvie Négrier, Sadya Khan, Jose Diaz, Suman Redhu, Faisal Mehmud, David Cella	Journal of Clinical Oncology	2014	13	12	10
10.1200/jco.2013.52.5188	Principles of Opioid Use in Cancer Pain	Russell K. Portenoy, Ebtesam Ahmed	Journal of Clinical Oncology	2014	12	12	6
10.1200/jco.2013.53.6136	Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment of HER2-Amplified Advanced Gastric Cancer in Asian Populations: TyTAN—A Randomized, Phase III Study	Taroh Satoh, Rui-Hua Xu, Hyun Cheol Chung, Guo-Ping Sun, Toshihiko Doi, Jian-Ming Xu, Akihito Tsuji, Yasushi Omuro, Jin Li, Jin-Wan Wang, Hiroto Miwa, Shu-Kui Qin, Ik-Joo Chung, Kun-Huei Yeh, Ji-Feng Feng, Akihira Mukaiyama, Mikiro Kobayashi, Atsushi Ohtsu, Yung-Jue Bang	Journal of Clinical Oncology	2014	13	12	4
10.1200/jco.2013.53.7746	SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma	Andrew X. Zhu, Olivier Rosmorduc, T.R. Jeffry Evans, Paul J. Ross, Armando Santoro, Flair Jose Carrilho, Jordi Bruix, Shukui Qin, Paul J. Thuluvath, Josep M. Llovet, Marie-Aude Leberre, Markus Jensen, Gerold Meinhardt, Yoon-Koo Kang	Journal of Clinical Oncology	2015	13	12	6
10.1200/jco.2014.55.1564	Acute Myeloid Leukemia and Myelodysplastic Syndromes in Older Adults	Heidi D. Klepin, Arati V. Rao, Timothy S. Pardee	Journal of Clinical Oncology	2014	13	12	7
10.1200/jco.2014.56.9590	Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31	Karen A. Gelmon, Frances M. Boyle, Bella Kaufman, David G. Huntsman, Alexey Manikhas, Angelo Di Leo, Miguel Martin, Lee S. Schwartzberg, Julie Lemieux, Samuel Aparicio, Lois E. Shepherd, Susan Dent, Susan L. Ellard, Katia Tonkin, Kathleen I. Pritchard, Timothy J. Whelan, Dora Nomikos, Arnd Nusch, Robert E. Coleman, Hirofumi Mukai, Sergei Tjulandin, Rustem Khasanov, Shulamith Rizel, Anne P. Connor, Sergio L. Santillana, Judith-Anne W. Chapman, Wendy R. Parulekar	Journal of Clinical Oncology	2015	26	12	6
10.1200/jco.2014.57.4756	Vitiligo-Like Depigmentation in Patients With Stage III-IV Melanoma Receiving Immunotherapy and Its Association With Survival: A Systematic Review and Meta-Analysis	Hansje-Eva Teulings, Jacqueline Limpens, Sophia N. Jansen, Aeilko H. Zwinderman, Johannes B. Reitsma, Phyllis I. Spuls, Rosalie M. Luiten	Journal of Clinical Oncology	2015	13	12	10
10.1200/jco.2014.58.9895	Next-Generation Strategies for Hereditary Colorectal Cancer Risk Assessment	Matthew B. Yurgelun	Journal of Clinical Oncology	2015	12	12	5
10.1200/jco.2014.59.0539	Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non–Small-Cell Lung Cancer and Brain Metastases	Daniel B. Costa, Alice T. Shaw, Sai-Hong I. Ou, Benjamin J. Solomon, Gregory J. Riely, Myung-Ju Ahn, Caicun Zhou, S. Martin Shreeve, Paulina Selaru, Anna Polli, Patrick Schnell, Keith D. Wilner, Robin Wiltshire, D. Ross Camidge, Lucio Crinò	Journal of Clinical Oncology	2015	13	12	9
10.1200/jco.2014.59.4812	Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment and RAS Mutations in Colorectal Cancer	Eric Van Cutsem, Heinz-Josef Lenz, Claus-Henning Köhne, Volker Heinemann, Sabine Tejpar, Ivan Melezínek, Frank Beier, Christopher Stroh, Philippe Rougier, J. Han van Krieken, Fortunato Ciardiello	Journal of Clinical Oncology	2015	13	12	7
10.1200/jco.2014.60.2219	SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma	Edgar Ben-Josef, Katherine A. Guthrie, Anthony B. El-Khoueiry, Christopher L. Corless, Mark M. Zalupski, Andrew M. Lowy, Charles R. Thomas, Steven R. Alberts, Laura A. Dawson, Kenneth C. Micetich, Melanie B. Thomas, Abby B. Siegel, Charles D. Blanke	Journal of Clinical Oncology	2015	12	12	7
10.1200/jco.2015.60.8620	Efficacy of Adjuvant Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer and Tumors ≤ 2 cm: A Meta-Analysis of the Randomized Trastuzumab Trials	Ciara C. O'Sullivan, Ian Bradbury, Christine Campbell, Marc Spielmann, Edith A. Perez, Heikki Joensuu, Joseph P. Costantino, Suzette Delaloge, Priya Rastogi, Dimitrios Zardavas, Karla V. Ballman, Eileen Holmes, Evandro de Azambuja, Martine Piccart-Gebhart, Jo Anne Zujewski, Richard D. Gelber	Journal of Clinical Oncology	2015	14	12	4
10.1200/jco.2013.49.7271	Cancer Genomics and Inherited Risk	Zsofia K. Stadler, Kasmintan A. Schrader, Joseph Vijai, Mark E. Robson, Kenneth Offit	Journal of Clinical Oncology	2014	12	11	7
10.1200/jco.2014.55.8536	Short-Term Risk of Colorectal Cancer in Individuals With Lynch Syndrome: A Meta-Analysis	Mark A. Jenkins, James G. Dowty, Driss Ait Ouakrim, John D. Mathews, John L. Hopper, Youenn Drouet, Christine Lasset, Valérie Bonadona, Aung Ko Win	Journal of Clinical Oncology	2015	12	11	7
10.1200/jco.2014.56.0383	Quality of Cancer Pain Management: An Update of a Systematic Review of Undertreatment of Patients With Cancer	Maria Teresa Greco, Anna Roberto, Oscar Corli, Silvia Deandrea, Elena Bandieri, Silvio Cavuto, Giovanni Apolone	Journal of Clinical Oncology	2014	11	11	7
10.1200/jco.2014.56.6018	Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial	Michele Maio, Jean-Jacques Grob, Steinar Aamdal, Igor Bondarenko, Caroline Robert, Luc Thomas, Claus Garbe, Vanna Chiarion-Sileni, Alessandro Testori, Tai-Tsang Chen, Marina Tschaika, Jedd D. Wolchok	Journal of Clinical Oncology	2015	14	11	11
10.1200/jco.2014.57.0572	Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)	William M. Sikov, Donald A. Berry, Charles M. Perou, Baljit Singh, Constance T. Cirrincione, Sara M. Tolaney, Charles S. Kuzma, Timothy J. Pluard, George Somlo, Elisa R. Port, Mehra Golshan, Jennifer R. Bellon, Deborah Collyar, Olwen M. Hahn, Lisa A. Carey, Clifford A. Hudis, Eric P. Winer	Journal of Clinical Oncology	2015	11	11	3
10.1200/jco.2014.57.9151	Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade	Philip J. Johnson, Sarah Berhane, Chiaki Kagebayashi, Shinji Satomura, Mabel Teng, Helen L. Reeves, James O'Beirne, Richard Fox, Anna Skowronska, Daniel Palmer, Winnie Yeo, Frankie Mo, Paul Lai, Mercedes Iñarrairaegui, Stephen L. Chan, Bruno Sangro, Rebecca Miksad, Toshifumi Tada, Takashi Kumada, Hidenori Toyoda	Journal of Clinical Oncology	2015	12	11	7
10.1200/jco.2014.58.1322	Hereditary Colorectal Cancer Syndromes: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the Familial Risk–Colorectal Cancer: European Society for Medical Oncology Clinical Practice Guidelines	Elena M. Stoffel, Pamela B. Mangu, Stephen B. Gruber, Stanley R. Hamilton, Matthew F. Kalady, Michelle Wan Yee Lau, Karen H. Lu, Nancy Roach, Paul J. Limburg	Journal of Clinical Oncology	2015	11	11	6
10.1200/jco.2014.60.7317	Phase III Multinational, Randomized, Double-Blind, Placebo-Controlled Study of Tivantinib (ARQ 197) Plus Erlotinib Versus Erlotinib Alone in Previously Treated Patients With Locally Advanced or Metastatic Nonsquamous Non–Small-Cell Lung Cancer	Giorgio Scagliotti, Joachim von Pawel, Silvia Novello, Rodryg Ramlau, Adolfo Favaretto, Fabrice Barlesi, Wallace Akerley, Sergey Orlov, Armando Santoro, David Spigel, Vera Hirsh, Frances A. Shepherd, Lecia V. Sequist, Alan Sandler, Jeffrey S. Ross, Qiang Wang, Reinhard von Roemeling, Dale Shuster, Brian Schwartz	Journal of Clinical Oncology	2015	13	11	6
10.1200/jco.2015.60.9271	Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer	Joseph A. Sparano, Fengmin Zhao, Silvana Martino, Jennifer A. Ligibel, Edith A. Perez, Tom Saphner, Antonio C. Wolff, George W. Sledge, William C. Wood, Nancy E. Davidson	Journal of Clinical Oncology	2015	12	11	7
10.1200/jco.2013.49.5523	Effects of Exercise on Treatment-Related Adverse Effects for Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Systematic Review	Jason R. Gardner, Patricia M. Livingston, Steve F. Fraser	Journal of Clinical Oncology	2014	11	10	8
10.1200/jco.2013.53.1194	Treatment of Hodgkin Lymphoma: A 50-Year Perspective	George P. Canellos, Saul A. Rosenberg, Jonathan W. Friedberg, T. Andrew Lister, Vincent T. DeVita	Journal of Clinical Oncology	2014	11	10	8
10.1200/jco.2013.53.1228	Recent Clinical Advances in Lung Cancer Management	David H. Johnson, Joan H. Schiller, Paul A. Bunn	Journal of Clinical Oncology	2014	11	10	9
10.1200/jco.2013.53.5229	Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group	Sally F. Barrington, N. George Mikhaeel, Lale Kostakoglu, Michel Meignan, Martin Hutchings, Stefan P. Müeller, Lawrence H. Schwartz, Emanuele Zucca, Richard I. Fisher, Judith Trotman, Otto S. Hoekstra, Rodney J. Hicks, Michael J. O'Doherty, Roland Hustinx, Alberto Biggi, Bruce D. Cheson	Journal of Clinical Oncology	2014	11	10	5
10.1200/jco.2013.54.3553	Neuroendocrine Prostate Cancer (NEPC) Progressing From Conventional Prostatic Adenocarcinoma: Factors Associated With Time to Development of NEPC and Survival From NEPC Diagnosis—A Systematic Review and Pooled Analysis	Hai Tao Wang, Yan Hong Yao, Bao Guo Li, Yong Tang, Ji Wu Chang, Jiao Zhang	Journal of Clinical Oncology	2014	12	10	5
10.1200/jco.2014.55.6894	Prediction of Late Distant Recurrence After 5 Years of Endocrine Treatment: A Combined Analysis of Patients From the Austrian Breast and Colorectal Cancer Study Group 8 and Arimidex, Tamoxifen Alone or in Combination Randomized Trials Using the PAM50 Risk of Recurrence Score	Ivana Sestak, Jack Cuzick, Mitch Dowsett, Elena Lopez-Knowles, Martin Filipits, Peter Dubsky, John Wayne Cowens, Sean Ferree, Carl Schaper, Christian Fesl, Michael Gnant	Journal of Clinical Oncology	2015	10	10	4
10.1200/jco.2014.57.3105	Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study--CALGB 30504 (Alliance)	N. E. Ready, H. H. Pang, L. Gu, G. A. Otterson, S. P. Thomas, A. A. Miller, M. Baggstrom, G. A. Masters, S. L. Graziano, J. Crawford, J. Bogart, E. E. Vokes	Journal of Clinical Oncology	2015	11	10	6
10.1200/jco.2014.57.3329	Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer	Kevin C. Conlon, Enrico Lugli, Hugh C. Welles, Steven A. Rosenberg, Antonio Tito Fojo, John C. Morris, Thomas A. Fleisher, Sigrid P. Dubois, Liyanage P. Perera, Donn M. Stewart, Carolyn K. Goldman, Bonita R. Bryant, Jean M. Decker, Jing Chen, Tat'Yana A. Worthy, William D. Figg, Cody J. Peer, Michael C. Sneller, H. Clifford Lane, Jason L. Yovandich, Stephen P. Creekmore, Mario Roederer, Thomas A. Waldmann	Journal of Clinical Oncology	2015	10	10	5
10.1200/jco.2014.57.7999	Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast Radiotherapy	Fei-Fei Liu, Wei Shi, Susan J. Done, Naomi Miller, Melania Pintilie, David Voduc, Torsten O. Nielsen, Sharon Nofech-Mozes, Martin C. Chang, Timothy J. Whelan, Lorna M. Weir, Ivo A. Olivotto, David R. McCready, Anthony W. Fyles	Journal of Clinical Oncology	2015	11	10	7
10.1200/jco.2014.58.7550	Evaluation of a Pharmacist-Led Medication Assessment Used to Identify Prevalence of and Associations With Polypharmacy and Potentially Inappropriate Medication Use Among Ambulatory Senior Adults With Cancer	Ginah Nightingale, Emily Hajjar, Kristine Swartz, Jocelyn Andrel-Sendecki, Andrew Chapman	Journal of Clinical Oncology	2015	10	10	6
10.1200/jco.2014.59.0166	Evidence-Based Diagnostic Algorithm for Glioma: Analysis of the Results of Pathology Panel Review and Molecular Parameters of EORTC 26951 and 26882 Trials	Johan M. Kros, Karin Huizer, Aurelio Hernández-Laín, Gianluca Marucci, Alex Michotte, Bianca Pollo, Elisabeth J. Rushing, Teresa Ribalta, Pim French, David Jaminé, Nawal Bekka, Denis Lacombe, Martin J. van den Bent, Thierry Gorlia	Journal of Clinical Oncology	2015	10	10	7
10.1200/jco.2014.59.0703	Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial	Robert J. Motzer, Brian I. Rini, David F. McDermott, Bruce G. Redman, Timothy M. Kuzel, Michael R. Harrison, Ulka N. Vaishampayan, Harry A. Drabkin, Saby George, Theodore F. Logan, Kim A. Margolin, Elizabeth R. Plimack, Alexandre M. Lambert, Ian M. Waxman, Hans J. Hammers	Journal of Clinical Oncology	2015	12	10	8
10.1200/jco.2014.59.0745	International Pediatric Non-Hodgkin Lymphoma Response Criteria	John T. Sandlund, R. Paul Guillerman, Sherrie L. Perkins, C. Ross Pinkerton, Angelo Rosolen, Catherine Patte, Alfred Reiter, Mitchell S. Cairo	Journal of Clinical Oncology	2015	11	10	8
10.1200/jco.2014.59.7328	Phase I/II Study of HSP90 Inhibitor AUY922 and Erlotinib for EGFR-Mutant Lung Cancer With Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors	M. L. Johnson, H. A. Yu, E. M. Hart, B. B. Weitner, A. W. Rademaker, J. D. Patel, M. G. Kris, G. J. Riely	Journal of Clinical Oncology	2015	11	10	4
10.1200/jco.2014.59.7351	Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014	Gary H. Lyman, Kari Bohlke, Alok A. Khorana, Nicole M. Kuderer, Agnes Y. Lee, Juan Ignacio Arcelus, Edward P. Balaban, Jeffrey M. Clarke, Christopher R. Flowers, Charles W. Francis, Leigh E. Gates, Ajay K. Kakkar, Nigel S. Key, Mark N. Levine, Howard A. Liebman, Margaret A. Tempero, Sandra L. Wong, Mark R. Somerfield, Anna Falanga	Journal of Clinical Oncology	2015	10	10	9
10.1200/jco.2014.60.0130	Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non–Small-Cell Lung Cancer: KCSG-LU05-04	Jin Seok Ahn, Yong Chan Ahn, Joo-Hang Kim, Chang Geol Lee, Eun Kyung Cho, Kyu Chan Lee, Ming Chen, Dong-Wan Kim, Hoon-Kyo Kim, Young Joo Min, Jin-Hyoung Kang, Jin-Hyuck Choi, Sang-We Kim, Guangying Zhu, Yi-Long Wu, Sung Rok Kim, Kyung Hee Lee, Hong Suk Song, Yoon-La Choi, Jong-Mu Sun, Sin-Ho Jung, Myung-Ju Ahn, Keunchil Park	Journal of Clinical Oncology	2015	10	10	8
10.1200/jco.2014.60.0734	Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial	Stefan S. Bielack, Sigbjørn Smeland, Jeremy S. Whelan, Neyssa Marina, Gordana Jovic, Jane M. Hook, Mark D. Krailo, Mark Gebhardt, Zsuzsanna Pápai, James Meyer, Helen Nadel, R. Lor Randall, Claudia Deffenbaugh, Rajaram Nagarajan, Bernadette Brennan, G. Douglas Letson, Lisa A. Teot, Allen Goorin, Daniel Baumhoer, Leo Kager, Mathias Werner, Ching C. Lau, Kirsten Sundby Hall, Hans Gelderblom, Paul Meyers, Richard Gorlick, Reinhard Windhager, Knut Helmke, Mikael Eriksson, Peter M. Hoogerbrugge, Paula Schomberg, Per-Ulf Tunn, Thomas Kühne, Heribert Jürgens, Henk van den Berg, Tom Böhling, Susan Picton, Marleen Renard, Peter Reichardt, Joachim Gerss, Trude Butterfass-Bahloul, Carol Morris, Pancras C.W. Hogendoorn, Beatrice Seddon, Gabriele Calaminus, Maria Michelagnoli, Catharina Dhooge, Matthew R. Sydes, Mark Bernstein	Journal of Clinical Oncology	2015	14	10	7
10.1200/jco.2014.60.1492	Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma	Erin L. Stewart, Celine Mascaux, Nhu-An Pham, Shingo Sakashita, Jenna Sykes, Lucia Kim, Naoki Yanagawa, Ghassan Allo, Kota Ishizawa, Dennis Wang, Chang-Qi Zhu, Ming Li, Christine Ng, Ni Liu, Melania Pintilie, Petra Martin, Tom John, Igor Jurisica, Natasha B. Leighl, Benjamin G. Neel, Thomas K. Waddell, Frances A. Shepherd, Geoffrey Liu, Ming-Sound Tsao	Journal of Clinical Oncology	2015	10	10	4
10.1200/jco.2013.51.8662	New Opioids	Sebastiano Mercadante, Giampiero Porzio, Vittorio Gebbia	Journal of Clinical Oncology	2014	9	9	8
10.1200/jco.2013.52.1377	Combining Targeted Therapy With Immunotherapy in BRAF-Mutant Melanoma: Promise and Challenges	Siwen Hu-Lieskovan, Lidia Robert, Blanca Homet Moreno, Antoni Ribas	Journal of Clinical Oncology	2014	11	9	3
